Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sertraline in Addition to Standard of Care Treatment for Coccidioidomycosis

NCT02908334 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT02908334
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02908334 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sertraline in Addition to Standard of Care Treatment for Coccidioidomycosis
Lead sponsor
University of California, San Francisco
Phase
Phase 2
Overall status
Withdrawn
Start date
November 30, 2016
Completion date
January 22, 2019
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

coccidioidomycosis